Trends in drug revenue among major pharmaceutical companies: A 2010-2019 cohort study.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer"
DOI: 10.1002/cncr.33934
Abstract: BACKGROUND Over the past 2 decades there has been a substantial increase in the number of new cancer medicines; this has been accompanied by a dramatic rise in drug costs. It is unknown how these… read more here.
Keywords: drug revenue; drug; 2010 2019; cancer ... See more keywords
The Abandoned Stakeholders: Pharmaceutical Companies and Research Participants
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Business Ethics"
DOI: 10.1007/s10551-016-3070-5
Abstract: Most discussions concerned with advancing the just and ethical treatment of research participants in developing countries have revolved around the moral principle of autonomy and the legal doctrine of informed consent (O’Neill 2002). However, if… read more here.
Keywords: research; abandoned stakeholders; companies research; pharmaceutical companies ... See more keywords
Coronavirus disease 2019 experts appearing on Japanese television: their characteristics and financial conflicts of interest with pharmaceutical companies
Sign Up to like & getrecommendations! Published in 2021 at "Clinical Microbiology and Infection"
DOI: 10.1016/j.cmi.2020.12.002
Abstract: Financial conflicts of interest between pharmaceutical companies and medical experts appearing on television remain opaque. We revealed that seven (63.6%) of the 11 medical experts on non-satellite Japanese television programs covering COVID-19 received a combined… read more here.
Keywords: financial conflicts; interest pharmaceutical; experts appearing; conflicts interest ... See more keywords
Health research and innovation: Can we optimize the interface between startups/pharmaceutical companies and academic health care institutions or not?
Sign Up to like & getrecommendations! Published in 2019 at "Therapie"
DOI: 10.1016/j.therap.2019.11.010
Abstract: Although France has numerous assets in the realm of health care, such as the excellence of its research teams, the reputation of its healthcare system, and the presence of many startups, all of which are… read more here.
Keywords: health care; innovation; health; interface ... See more keywords
Identification of β-Lactams Active against Mycobacterium tuberculosis by a Consortium of Pharmaceutical Companies and Academic Institutions
Sign Up to like & getrecommendations! Published in 2022 at "ACS Infectious Diseases"
DOI: 10.1021/acsinfecdis.1c00570
Abstract: Rising antimicrobial resistance challenges our ability to combat bacterial infections. The problem is acute for tuberculosis (TB), the leading cause of death from infection before COVID-19. Here, we developed a framework for multiple pharmaceutical companies… read more here.
Keywords: identification lactams; tuberculosis; consortium; mycobacterium tuberculosis ... See more keywords
Pricing Retrovir: Wellcome PLC and the Role of Pharmaceutical Companies in the Global AIDS Crisis, 1986 to 1991
Sign Up to like & getrecommendations! Published in 2022 at "Journal of the History of Medicine and Allied Sciences"
DOI: 10.1093/jhmas/jrac027
Abstract: ABSTRACT:In spring 1987, British pharmaceutical company Wellcome PLC released azidothymidine (AZT) sold under trade name Retrovir, the first successful treatment for AIDS. In the context of a global public health emergency and with no competing… read more here.
Keywords: pricing retrovir; company; pharmaceutical companies; wellcome plc ... See more keywords
Collaboration: the key to gain value from IT in supply chain
Sign Up to like & getrecommendations! Published in 2018 at "Euromed Journal of Business"
DOI: 10.1108/emjb-12-2017-0051
Abstract: The purpose of this paper is to investigate the role of electronic collaboration (e-collaboration) including information sharing, resource sharing and joint knowledge creation in value creation within pharmaceutical supply chain (SC) and achieving competitive priorities… read more here.
Keywords: creation; information; value; collaboration ... See more keywords
Use of cloud model to evaluate corporate social responsibility of pharmaceutical companies
Sign Up to like & getrecommendations! Published in 2022 at "Kybernetes"
DOI: 10.1108/k-12-2020-0850
Abstract: Purpose Based on the perspective of stakeholders, this paper aims to construct the corporate social responsibility (CSR) evaluation system, aiming at encouraging enterprises to actively undertake social responsibility, formulating targeted countermeasures to improve the performance… read more here.
Keywords: cloud model; pharmaceutical companies; evaluation; social responsibility ... See more keywords
Making pharmaceutical companies report what matters about innovation.
Sign Up to like & getrecommendations! Published in 2021 at "British journal of clinical pharmacology"
DOI: 10.1111/bcp.14993
Abstract: There is a lack of transparency about the cost of innovation of the pharmaceutical industry even though these costs are claimed to be the major driver for high prices for medicines. This is reflected by… read more here.
Keywords: report matters; companies report; pharmacology; matters innovation ... See more keywords
Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study
Sign Up to like & getrecommendations! Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j3334
Abstract: Objectives To identify the policies of major pharmaceutical companies on transparency of trials, to extract structured data detailing each companies’ commitments, and to assess concordance with ethical and professional guidance. Design Structured audit. Setting Pharmaceutical… read more here.
Keywords: share; policy; trial; summary results ... See more keywords
Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016
Sign Up to like & getrecommendations! Published in 2020 at "BMJ Open"
DOI: 10.1136/bmjopen-2020-037395
Abstract: Objective To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex. Design and participants Cohort study of all German HCPs who voluntarily… read more here.
Keywords: hcps; payment; disclosure; 2015 2016 ... See more keywords